Flagship Venturelabs' start-up Rubius moving RCTs toward clinic
Armed with an initial $25 million investment from Flagship Ventures, Rubius Therapeutics Inc. is on its way to the clinic with a new therapeutic modality designed to harness the natural ability of red blood cells to interact with and modulate the immune system.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST